AlphaVax Names VP of Business Development.Business Editors, Health and Medical Writers REPEATING... DURHAM, N.C.--(BW HeatlhWire)--July 31, 2000 Janice A. Kimpel has been named Vice President of Business Development for AlphaVax Inc., a vaccine vaccine Preparation containing either killed or weakened live microorganisms or their toxins, introduced by mouth, by injection, or by nasal spray to stimulate production of antibodies against an infectious agent. development company based in Durham. She recently worked as a science adviser and patent agent for Needle & Rosenburg, an intellectual property firm in Atlanta, before coming to AlphaVax. "We are extremely pleased to have someone of Janice's caliber on our team," said Peter F. Young, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of AlphaVax. "Janice's licensing experience will be of immediate value in our rapidly expanding pattern of external partnerships. Her intellectual property expertise and direct familiarity with the AlphaVax patent family will also be of great benefit as we build and extend our intellectual property platform." Prior to her work at the law firm, Kimpel was a director of technological licensing at the University of Georgia Organization The President of the University of Georgia (as of 2007, Michael F. Adams) is the head administrator and is appointed and overseen by the Georgia Board of Regents. , where she was responsible for licensing diverse technologies, including pharmaceuticals, veterinary vaccines and recombinant DNA recombinant DNA n. Genetically engineered DNA prepared by transplanting or splicing one or more segments of DNA into the chromosomes of an organism from a different species. Such DNA becomes part of the host's genetic makeup and is replicated. discoveries. She also served as the external contracts research manager for an agricultural biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. firm, with responsibility for a significant intellectual property and research portfolio. Kimpel earned her Ph.D. in plant biology from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). at Davis. AlphaVax is working to develop and commercialize a proprietary vaccine vector technology with properties that show significant promise in creating better, more effective vaccines. The company has recently focused on establishing the technology's regulatory and manufacturing platform, anticipating plans to begin clinical trials early next year. The company also plans to expand its organization, is talking with a growing list of potential corporate partners, and announced recently that it had raised more than $19 million in private investment funds Noun 1. investment funds - money that is invested with an expectation of profit investment assets - anything of material value or usefulness that is owned by a person or company this year. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion